Table 5 10-fold cross validation model performance to identify at risk groups.

From: Plasma N-glycans in colorectal cancer risk

Peaks + features

AUC

Sensitivity

Specificity

p-value

All peaks + age

0.651

0.125

0.950

*

All peaks

0.612

0.150

0.950

<0.0001

  1. Discrimination models tested on the FINRISK dataset. ‘All peaks’: 39 peak areas and ‘All peaks + age’: all 39 peak areas and age of each person in the FINRISK dataset. P-value column: ‘*’ best model, P-value AUC different from best model.
Back to article page